Paper16687489
Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells.
Wischnewski F and 2 others. Mol Cancer Res, 2006. Cited by 158 papers, by iCite.
Cite this record
ConductScience Library. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. Papers, record 16687489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16687489
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Azacitidine | Major topic |
| DNA Methylation | Major topic |
| Histones | Major topic |
| Hydroxamic Acids | Major topic |
| Neoplasms | Major topic |
| Acetylation | |
| Blotting, Western | |
| Cell Line, Tumor | |
| Corynebacterium | |
| DNA Modification Methylases | |
| Decitabine | |
| Gene Expression Regulation, Neoplastic | |
| Histone Deacetylase Inhibitors | |
| Histone Deacetylases | |
| Humans | |
| Melanoma-Specific Antigens | |
| Neoplasm Proteins | |
| Promoter Regions, Genetic |
Source PubMed
Cited by85
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 158 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41465204 | Intratumoral Heterogeneity of MAGED4 Expression in Oral Squamous Cell Carcinoma: Epigenetic Mechanisms and Therapeutic Implications. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465204 | PubMed |
| 40218304 | Preliminary Exploration of MAGE-B1, -B4, -B5, and -B10 mRNA Expression in Canine Mammary Tumors in Dogs. | Animals (Basel) | 2025 | https://conductscience.org/library/papers/40218304 | PubMed |
| 39970827 | Melanoma-associated antigen A4: A cancer/testis antigen as a target for adoptive T-cell receptor T-cell therapy. | Cancer Treat Rev | 2025 | https://conductscience.org/library/papers/39970827 | PubMed |
| 39883700 | Identification of cuproptosis and ferroptosis-related subtypes and development of a prognostic signature in colon cancer. | PLoS One | 2025 | https://conductscience.org/library/papers/39883700 | PubMed |
| 39472405 | Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in glioma. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39472405 | PubMed |
| 39082035 | Expression pattern analysis of the MAGE family genes in breast cancer patients and hypomethylation activation in the MCF-7 cells. | Heliyon | 2024 | https://conductscience.org/library/papers/39082035 | PubMed |
| 38058537 | Epigenome-Driven Strategies for Personalized Cancer Immunotherapy. | Cancer Manag Res | 2023 | https://conductscience.org/library/papers/38058537 | PubMed |
| 37809078 | Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37809078 | PubMed |
| 37144487 | Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review). | Int J Oncol | 2023 | https://conductscience.org/library/papers/37144487 | PubMed |
| 36980665 | The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy? | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980665 | PubMed |
| 36980267 | Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer. | Cells | 2023 | https://conductscience.org/library/papers/36980267 | PubMed |
| 35937396 | Expression Profile of MAGE-B1 Gene and Its Hypomethylation Activation in Colon Cancer. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/35937396 | PubMed |
| 35756177 | Immune Checkpoint Blockade in Gastrointestinal Cancers: The Current Status and Emerging Paradigms. | J Immunother Precis Oncol | 2020 | https://conductscience.org/library/papers/35756177 | PubMed |
| 35582723 | Resistance to cis- and carboplatin initiated by epigenetic changes in ovarian cancer patients. | Cancer Drug Resist | 2019 | https://conductscience.org/library/papers/35582723 | PubMed |
| 35140720 | A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy. | Front Immunol | 2022 | https://conductscience.org/library/papers/35140720 | PubMed |
| 34970496 | Comprehensive Analysis to Identify MAGEA3 Expression Correlated With Immune Infiltrates and Lymph Node Metastasis in Gastric Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34970496 | PubMed |
| 34837545 | Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progression. | J Cancer Res Clin Oncol | 2022 | https://conductscience.org/library/papers/34837545 | PubMed |
| 34830845 | Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34830845 | PubMed |
| 34630870 | Epigenetic mechanisms of liver tumor resistance to immunotherapy. | World J Hepatol | 2021 | https://conductscience.org/library/papers/34630870 | PubMed |
| 34365035 | Epigenetic strategies to boost CAR T cell therapy. | Mol Ther | 2021 | https://conductscience.org/library/papers/34365035 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MAGEA1 | 4100 | PubTator's text mining | https://conductscience.org/library/genes/4100 | NCBI Gene |
| MAGEA12 | 4111 | PubTator's text mining | https://conductscience.org/library/genes/4111 | NCBI Gene |
| MAGEA2 | 4101 | PubTator's text mining | https://conductscience.org/library/genes/4101 | NCBI Gene |
| MAGEA3 | 4102 | PubTator's text mining | https://conductscience.org/library/genes/4102 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16687489
GET https://conductscience.org/api/papers/v1/16687489/cited_by?page=2